|Ersatz Systems Machine Cognition, LLC|
|Let the bits speak for themselves.||Home|
|Welcome||Place Order||Articles||Requirements||Bivalent Neuron BVN||Contacts||Acceptable Use|
|Posters||Scalability||φΦ Phigit Computing|
|Slide Shows||Portability||Standard Notation|
|US Patents||Training||Patent Licenses|
|Ersatz Systems Machine Cognition, LLC (ESMC) sells services, tools, and software and hardware for bivalent technology such as:
Method and system for the Kanban cell neuron network, US Patent 9,202,166 (issued 12/01/2015); and Method and system for prediction of time series by Kanban neuron model, US Patent 9,501,737 (issued 11/22/2016).
Our focus now is on licensing the Meth8/VŁ4 software product, a modal logic model checker implementing the universal logic system VŁ4.
The KCNN Model applies to the prediction of trading signals for financial markets such as 10-year treasuries and five disparate commodities. This is named the Kanban cell neuron stock trading system (KCNSTS). A book for Chinese and Asian ETFs from December, 2014 shows an annualized profit.
The Meth8/VŁ4 modal logic model checker is now available for single-seat licensing with unlimited table lookup accesses. The two products for sale are scaled: $99.97 as four theorems (A, B, C, D) and four propositions (p, q, r, s); and $149.97 as 11-propositions (p, ... , z). Here is a manifest with further scalability pricing. Standard discounts apply to qualified resellers and university computer labs. A free student demo program in two-variables with unlimited sequents is available on request.
Published details are in the model table definitions, a current abstract with results and toc is herein, and over 600 papers are available elsewhere and by request. Here is an example of what we do: ''Refutation of the quaternion based on its implication table".
All software and hardware services are based on flat rate bids and prices. Other products, papers, and free software source code are at cec-services.com.
For sponsors supporting disruptive technology from recent advances of independent research, please inquire at: "email@example.com".